Igcasan, Denys .

HRN: 18-13-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFUROXIME 750MG (VIAL)
07/01/2026
07/08/2026
IVTT
590mg
Q8h
PCAP-B
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: